First Financial Bankshares Inc Purchases 108 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

First Financial Bankshares Inc lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,246 shares of the medical equipment provider’s stock after purchasing an additional 108 shares during the quarter. First Financial Bankshares Inc’s holdings in Intuitive Surgical were worth $3,068,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Ullmann Wealth Partners Group LLC lifted its holdings in shares of Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after acquiring an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC boosted its holdings in Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after acquiring an additional 23 shares during the period. Daymark Wealth Partners LLC grew its position in Intuitive Surgical by 0.3% during the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock worth $3,452,000 after acquiring an additional 24 shares during the last quarter. Indiana Trust & Investment Management CO lifted its position in Intuitive Surgical by 5.3% in the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after purchasing an additional 25 shares during the last quarter. Finally, Hoxton Planning & Management LLC boosted its stake in shares of Intuitive Surgical by 4.9% during the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after purchasing an additional 25 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares of the company’s stock, valued at approximately $140,595. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 51,816 shares of company stock worth $25,230,649. 0.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Raymond James increased their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Morgan Stanley raised their target price on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Citigroup lifted their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, Royal Bank of Canada boosted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $511.27 on Monday. The business has a fifty day moving average price of $487.98 and a 200-day moving average price of $443.05. The company has a market capitalization of $182.10 billion, a PE ratio of 82.20, a PEG ratio of 5.11 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $523.34.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.